<SEC-DOCUMENT>0001193125-20-262640-index.html : 20201002
<SEC-HEADER>0001193125-20-262640.hdr.sgml : 20201002
<ACCEPTANCE-DATETIME>20201002171829
ACCESSION NUMBER:		0001193125-20-262640
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20201002
DATE AS OF CHANGE:		20201002
EFFECTIVENESS DATE:		20201002

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			C4 Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001662579
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				475617627
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-249286
		FILM NUMBER:		201221223

	BUSINESS ADDRESS:	
		STREET 1:		490 ARSENAL WAY
		STREET 2:		SUITE 200
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
		BUSINESS PHONE:		(617) 231-0700

	MAIL ADDRESS:	
		STREET 1:		490 ARSENAL WAY
		STREET 2:		SUITE 200
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d60538ds8.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: d60538ds8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d60538dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: d60538dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d60538dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 3 - file: d60538dex231.htm

</DOCUMENT>
</SEC-DOCUMENT>